HempNewsBreaks – Pivot Pharmaceuticals (PVOTF) and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids
Pivot Pharmaceuticals (OTCQB: PVOTF) and its medical cannabis product division, Pivot Green Stream Health Solutions, recently announced the signing of a definitive agreement with Solmic Research GmbH (Germany) which gives Pivot Pharmaceuticals worldwide rights to Solmic Solubilisation Technology for the development and commercialization of cannabinoid-containing natural extracts. Solmic’s proprietary technology provides higher bioavailability and stability compared to alternative oil-based formulations. Solmic’s technology allows active ingredients to become water soluble without changing their composition and nature. To view the full article, visit http://cnw.fm/Ew0e4 About Pivot Pharmaceuticals Inc. Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company…